Characteristics of patients with HES treated with imatinib
. | Median . | Range . |
|---|---|---|
| Age, y | 50 | 25-73 |
| Time from diagnosis, mo | 35 | 8-142 |
| No. prior therapies | 2 | 0-7 |
| WBC count, × 109/L | 9.4 | 6.2-17.5 |
| Peripheral eosinophils, % | 21 | 2-68 |
| Peripheral absolute eosinophil count, × 109/L | 1.8 | 0.3-6.6 |
| Marrow eosinophils, % | 18 | 10-44 |
. | Median . | Range . |
|---|---|---|
| Age, y | 50 | 25-73 |
| Time from diagnosis, mo | 35 | 8-142 |
| No. prior therapies | 2 | 0-7 |
| WBC count, × 109/L | 9.4 | 6.2-17.5 |
| Peripheral eosinophils, % | 21 | 2-68 |
| Peripheral absolute eosinophil count, × 109/L | 1.8 | 0.3-6.6 |
| Marrow eosinophils, % | 18 | 10-44 |
The male-to-female ratio of patients was 6:3.